TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - EVOTEC Share Price

Certificat

DE000SN47VT7

Delayed Deutsche Boerse AG 15:57:00 28/06/2024 BST
2.03 EUR -1.46% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - EVOTEC
1 month+3.52%
3 months+38.26%
Date Price Change
28/06/24 2.03 -1.46%
27/06/24 2.06 +1.48%
26/06/24 2.03 0.00%
25/06/24 2.03 -1.46%
24/06/24 2.06 -0.96%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 03:57 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying EVOTEC SE
IssuerLogo Issuer Société Générale Société Générale
WKN SN47VT
ISINDE000SN47VT7
Date issued 21/07/2022
Strike 29.05
Maturity Unlimited
Parity 10 : 1
Emission price 0.52
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.18
Lowest since issue 0.086

Company Profile

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Sector
-
More about the company

Ratings for Evotec SE

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Evotec SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
8.48 EUR
Average target price
20.79 EUR
Spread / Average Target
+145.17%
Consensus